Neuraxis Inc (NRXS) Stock Price, Quote & News

Company Profile

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a...

Industry: Biotechnology

Sector: Healthcare

Phone: 812 689 0791

Website: neuraxis.com

Address:

11611 North Meridian St, Suite 330, Carmel, United States

Finnish_boy Apr. 4 at 12:14 PM

$NRXS I think they have won during Q1 and will win during Q2 smaller coverages and they know they are going to win major coverages late Q2. Bigger policy changes in June/July. I expect huge news in June. On next earnings mgt will comment about this. Q1 revenue will be nicely up also. Anthem informed PENFS changes 18th december. NRXS press release 19th. Coverage kicked in 1st January.

1 · Reply

Toptradersam Apr. 3 at 7:42 PM

$GNPX $NRXS $ZBCN.X $RXRX Don’t ignore this $1.5 penny stock ⚠️ Momentum could hit FAST 💸 See why in my latest video 👇 https://www.youtube.com/watch?v=mKJv0sQCxdY

0 · Reply

Millardi Apr. 3 at 7:37 PM

$NRXS lets go nrxs moon this is the hype i like it imo coverage soon pls stay ready tick tock jk major upside catalyst path to follow

1 · Reply

WallStreetBuyDip Apr. 3 at 7:11 PM

Comparing trending tickers $NRXS vs $QUIK: NRXS has climbed slightly by 0.97% to $7.25, with today's trading volume at 44.0K, notably below its average of 622.2K. On the other hand, QUIK has dipped by 0.30% to $9.95, trading 133.1K shares today, which is also below its usual volume of 186.0K. NRXS is showing a minor gain despite a significant drop in trading volume, while QUIK's slight decrease comes with moderately reduced activity.

0 · Reply

Finnish_boy Apr. 3 at 5:59 PM

$NRXS April is the most active review window. UHC, Cigna, Aetna, BCBS ????

1 · Reply

Finnish_boy Apr. 3 at 5:48 PM

$NRXS TICK TOCK.. major coverage news in 1-3 months.

0 · Reply

CEOBuysDisclosures Apr. 3 at 5:25 PM

$NRXS CEO purchased 8,060 shares at $1.96 for a total of $15,798. Carrico Brian Allen now owns 348,178 shares. https://ceo-buys.com

0 · Reply

Lets_Go_Brndn Mar. 31 at 7:44 PM

$GLSI $VLTLF $VKTX $ARDX $NRXS Portfolio going crazy!

2 · Reply

S144 Mar. 29 at 7:17 PM

$NRXS NeurAxis: What a CPT Category I Code Actually Does to a Stock https://microcapopportunities.substack.com/p/neuraxis-what-a-cpt-category-i-code

0 · Reply

stocktrader1549 Mar. 23 at 5:23 PM

$NRXS terrible ER, they’re losing $

3 · Reply

NeurAxis, Inc. (NRXS) Q4 2025 Earnings Call Transcript

Mar 19, 2026, 7:05 AM EDT - 17 days ago

NeurAxis Reports Strong Fourth Quarter and Full Year 2025 Financial Results

Nov 11, 2025, 2:51 PM EST - 5 months ago

NeurAxis, Inc. (NRXS) Q3 2025 Earnings Call Transcript

Nov 11, 2025, 7:00 AM EST - 5 months ago

NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues

Aug 12, 2025, 12:29 PM EDT - 8 months ago

NeurAxis, Inc. (NRXS) Q2 2025 Earnings Call Transcript

Jun 17, 2025, 8:00 AM EDT - 10 months ago

NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives

May 22, 2025, 1:03 PM EDT - 11 months ago

NeurAxis Announces Closing of $5.0 Million Registered Direct Offering

May 21, 2025, 7:00 AM EDT - 11 months ago

NeurAxis Announces $5.0 Million Registered Direct Offering

May 12, 2025, 1:58 PM EDT - 11 months ago

NeurAxis, Inc. (NRXS) Q1 2025 Earnings Call Transcript

May 12, 2025, 8:15 AM EDT - 11 months ago

NeurAxis Reports Strong First Quarter 2025 Financial Results Driven by a 39% Growth in Revenues

May 5, 2025, 9:00 AM EDT - 11 months ago

NeurAxis to Host First Quarter 2025 Results and Business Update Call on Monday, May 12, 2025

Mar 20, 2025, 4:18 PM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 8:15 AM EDT - 1 year ago

NeurAxis Reports Strong Fourth Quarter 2024 Financial Results Driven by a 43% Increase in Revenues

Mar 12, 2025, 9:00 AM EDT - 1 year ago

NeurAxis to Host Fourth Quarter and Full Year 2024 Results and Business Update Call on Thursday, March 20, 2025

Jan 21, 2025, 1:45 PM EST - 1 year ago

UPDATE - NeurAxis Announces New Medical Policy Coverage with a Prominent Insurer for Over Five Million Lives Across Multiple States

Jan 21, 2025, 9:00 AM EST - 1 year ago

NeurAxis Announces New Medical Policy Coverage with Molina Healthcare for Over Five Million Lives Across Multiple States

Jan 13, 2025, 9:00 AM EST - 1 year ago

NeurAxis Inc. Issues Letter to Shareholders

Jan 6, 2025, 9:00 AM EST - 1 year ago

NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Nov 15, 2024, 2:04 PM EST - 1 year ago

NeurAxis, Inc (NRXS) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 8:10 AM EST - 1 year ago

NeurAxis Reports Strong Third Quarter 2024 Financial Results Driven by a 40% Increase in Revenues

Oct 22, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation

Sep 19, 2024, 9:00 AM EDT - 1 year ago

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024

Aug 27, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024

Aug 13, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024

Aug 11, 2024, 5:44 AM EDT - 1 year ago

NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 8:00 AM EDT - 1 year ago

NeurAxis Reports Second Quarter 2024 Financial Results

Jun 7, 2024, 9:00 AM EDT - 1 year ago

NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure

May 22, 2024, 1:34 PM EDT - 2 years ago

NeurAxis, Inc. (NRXS) Q1 2024 Earnings Call Transcript

May 22, 2024, 8:00 AM EDT - 2 years ago

NeurAxis Reports First Quarter 2024 Financial Results

May 21, 2024, 9:00 AM EDT - 2 years ago

NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024

May 15, 2024, 4:30 PM EDT - 2 years ago

NeurAxis to Host First Quarter 2024 Results and Business Update Call on Wednesday, May 22, 2024

Apr 23, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces New Medical Policy Coverage in North Dakota

Apr 9, 2024, 6:45 PM EDT - 2 years ago

NeurAxis, Inc. (NRXS) Q4 2023 Earnings Call Transcript

Apr 9, 2024, 4:05 PM EDT - 2 years ago

NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Apr 1, 2024, 4:15 PM EDT - 2 years ago

NeurAxis to Host Fourth Quarter and Full Year 2023 Results and Business Update Call on Tuesday, April 9, 2024

Mar 27, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces IB-Stim Results from a Large, Pediatric, Multi-Center Registry

Mar 11, 2024, 9:00 AM EDT - 2 years ago

NeurAxis Announces Highmark BCBS Policy Coverage

Mar 4, 2024, 9:00 AM EST - 2 years ago

NeurAxis Announces Blue Cross and Blue Shield of Kansas City Policy Coverage

Feb 27, 2024, 11:00 AM EST - 2 years ago

NeurAxis to Present at Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Jan 31, 2024, 9:00 AM EST - 2 years ago

NeurAxis Appoints Timothy Henrichs as Chief Financial Officer

Dec 20, 2023, 9:00 AM EST - 2 years ago

NeurAxis, Inc. Issues Letter to Shareholders from Brian Carrico, President and Chief Executive Officer

Nov 20, 2023, 5:30 PM EST - 2 years ago

NeurAxis Reports Third Quarter 2023 Financial Results

Nov 15, 2023, 9:00 AM EST - 2 years ago

NeurAxis Announces CareFirst BCBS Policy Coverage

Nov 14, 2023, 9:00 AM EST - 2 years ago

NeurAxis Secures $3 Million Financing

Nov 8, 2023, 9:00 AM EST - 2 years ago

NeurAxis Signs Exclusive Option Agreement with University of Michigan for Innovative Gastrointestinal Device

Sep 21, 2023, 8:00 AM EDT - 2 years ago

NeurAxis Reports Second Quarter 2023 Financial Results

Sep 13, 2023, 9:00 AM EDT - 2 years ago

NeurAxis to Present at the Gilmartin Group Emerging Growth Showcase

Sep 12, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Announces Publication of Prospective Study Showing IB-Stim™ Improves Quality of Life of Adolescents with IBS

Aug 29, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Pediatric Post-Concussion Clinical Study

Aug 24, 2023, 9:00 AM EDT - 2 years ago

NeurAxis Highlights Strength of its Board of Directors

Finnish_boy Apr. 4 at 12:14 PM

1 · Reply

Toptradersam Apr. 3 at 7:42 PM

$GNPX $NRXS $ZBCN.X $RXRX Don’t ignore this $1.5 penny stock ⚠️ Momentum could hit FAST 💸 See why in my latest video 👇 https://www.youtube.com/watch?v=mKJv0sQCxdY

0 · Reply

Millardi Apr. 3 at 7:37 PM

$NRXS lets go nrxs moon this is the hype i like it imo coverage soon pls stay ready tick tock jk major upside catalyst path to follow

1 · Reply

WallStreetBuyDip Apr. 3 at 7:11 PM

0 · Reply

Finnish_boy Apr. 3 at 5:59 PM

$NRXS April is the most active review window. UHC, Cigna, Aetna, BCBS ????

1 · Reply

Finnish_boy Apr. 3 at 5:48 PM

$NRXS TICK TOCK.. major coverage news in 1-3 months.

0 · Reply

CEOBuysDisclosures Apr. 3 at 5:25 PM

$NRXS CEO purchased 8,060 shares at $1.96 for a total of $15,798. Carrico Brian Allen now owns 348,178 shares. https://ceo-buys.com

0 · Reply

Lets_Go_Brndn Mar. 31 at 7:44 PM

$GLSI $VLTLF $VKTX $ARDX $NRXS Portfolio going crazy!

2 · Reply

S144 Mar. 29 at 7:17 PM

$NRXS NeurAxis: What a CPT Category I Code Actually Does to a Stock https://microcapopportunities.substack.com/p/neuraxis-what-a-cpt-category-i-code

0 · Reply

stocktrader1549 Mar. 23 at 5:23 PM

$NRXS terrible ER, they’re losing $

3 · Reply

S144 Mar. 23 at 2:15 AM

$NRXS M. V. Cunha made his NRXS article public (free access): "NeurAxis (NRXS): Update Following Q4 Results": https://mvcinvesting.substack.com/p/neuraxis-nrxs-update-following-q4

0 · Reply

Doozio Mar. 21 at 9:18 PM

$NRXS da huckleberries thru da $$ during this 🐑 💩???

0 · Reply

Lets_Go_Brndn Mar. 20 at 5:29 PM

$NRXS Long.

0 · Reply

S144 Mar. 19 at 7:10 PM

$NRXS https://microcapopportunities.substack.com/p/neuraxis-last-call-before-full-commercialization

0 · Reply

S144 Mar. 19 at 4:16 PM

$NRXS https://substack.com/home/post/p-191463162

0 · Reply

stockinvestor102 Mar. 19 at 11:10 AM

$NRXS https://ir.neuraxis.com/news-releases/news-release-details/neuraxis-reports-strong-fourth-quarter-and-full-year-2025/

0 · Reply

Earlyretire777 Mar. 18 at 11:41 AM

$NRXS Building a starter position here. I like the risk/reward.

0 · Reply

Finnish_boy Mar. 18 at 10:18 AM

$NRXS Multibagger for sure. I am looking for $28 in 3 years. 7.5 P/S * $75M /20M = $28 Adults open in 3 years. That's why higher multiple than 5 P/S https://mvcinvesting.substack.com/p/my-new-position-investment-thesis

1 · Reply

stockinvestor102 Mar. 12 at 5:09 PM

Bought shares of $NRXS

1 · Reply

Andyc545 Mar. 11 at 2:48 AM

$NRXS ATH!! and this board is quiet...

1 · Reply

S144 Mar. 10 at 6:17 PM

$NRXS +11% today ! @alexpitti

1 · Reply

wallstpirate Mar. 2 at 5:11 PM

$NRXS Amazing video https://microcapclub.com/neuraxis-nrxs-growth-stage-medtech/

0 · Reply

Market Cap	81.11M
Revenue (ttm)	3.57M
Net Income (ttm)	-7.80M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-218.49%
Debt to Equity Ratio	0.00

Volume	44,000
Avg Vol	151,074
Day's Range	N/A - N/A
Shares Out	11.19M
Stochastic %K	60%
Beta	1.89
Analysts	Strong Sell
Price Target	$13.00